The relationship between hyperpolypharmacy and one-year outcomes in patients with critical limb ischemia undergoing below-knee endovascular therapy

CONCLUSION: Hyperpolypharmacy was significantly associated with 1-year mortality and major amputation in CLI patients. Hyperpolypharmacy can be a valuable aid in patient risk assessment in the CLI.PMID:38095298 | DOI:10.1177/17085381231193496

Source: Vascular - December 14, 2023 Category: Surgery Authors: Mehmet Altunova Recep Gulmez Muammer Karakayali Ismail Gurbak Omer Tasbulak G ökhan Demirci Arda Guler Ali Evsen Umit Bulut Mehmet Erturk Source Type: research